These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38788311)

  • 1. How hereditary cancer risk disclosure to relatives is handled in practice - Patient perspectives from a Swedish cancer genetics clinic.
    Hawranek C; Rosén A; Hajdarevic S
    Patient Educ Couns; 2024 Sep; 126():108319. PubMed ID: 38788311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial.
    Eijzenga W; de Geus E; Aalfs CM; Menko FH; Sijmons RH; de Haes HCJM; Smets EMA
    Patient Educ Couns; 2018 Sep; 101(9):1611-1619. PubMed ID: 29789176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer.
    Öfverholm A; Karlsson P; Rosén A
    Eur J Hum Genet; 2024 May; 32(5):539-544. PubMed ID: 38355958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.
    de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM
    Trials; 2014 Mar; 15():86. PubMed ID: 24649895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disclosing cancer genetic information within families: perspectives of counselees and their at-risk relatives.
    Hayat Roshanai A; Lampic C; Rosenquist R; Nordin K
    Fam Cancer; 2010 Dec; 9(4):669-79. PubMed ID: 20577820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations-A Qualitative Study.
    Bednar EM; Rauh-Hain JA; Garcia JJ; de Aguinaga N; Powell MA; Peral SL; Nitecki R; Jorgensen K; Rudy NL; Lu KH; Leath CA; Scarinci IC
    Cancer Prev Res (Phila); 2024 Jan; 17(1):19-28. PubMed ID: 37913800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
    Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
    Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?--a randomized study.
    Roshanai AH; Rosenquist R; Lampic C; Nordin K
    Acta Oncol; 2009; 48(7):999-1009. PubMed ID: 19636983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Test Results and Disclosure to Family Members: Qualitative Interviews of Healthcare Professionals' Perceptions of Ethical and Professional Issues in France.
    D' Audiffret Van Haecke D; de Montgolfier S
    J Genet Couns; 2016 Jun; 25(3):483-94. PubMed ID: 26482743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Relational Approach to Genetic Counseling for Hereditary Breast and Ovarian Cancer.
    Forbes Shepherd R; Browne TK; Warwick L
    J Genet Couns; 2017 Apr; 26(2):283-299. PubMed ID: 27761849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "I have always lived with the disease in the family": family adaptation to hereditary cancer-risk.
    Silva E; Gomes P; Matos PM; Silva ER; Silva J; Brandão C; Castro F; Neves MC; Sales CMD
    BMC Prim Care; 2022 Apr; 23(1):93. PubMed ID: 35461227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics.
    Derbez B; de Pauw A; Stoppa-Lyonnet D; de Montgolfier S
    Fam Cancer; 2017 Jul; 16(3):447-457. PubMed ID: 28293859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children.
    Sharff ME; DeMarco TA; Mays D; Peshkin BN; Valdimarsdottir HB; Garber JE; Schneider KA; Patenaude AF; Tercyak KP
    Genet Test Mol Biomarkers; 2012 May; 16(5):376-82. PubMed ID: 22085394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal perceptions of BRCA genetic counseling communication processes about disclosing cancer risk information to children and adult relatives.
    Hamilton JG; Peshkin BN; Mays D; DeMarco TA; Patenaude AF; Tercyak KP
    Psychooncology; 2018 Jul; 27(7):1825-1832. PubMed ID: 29645321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a "right time" for bad news? Kairos in familial communication on hereditary breast and ovarian cancer risk.
    Derbez B
    Soc Sci Med; 2018 Apr; 202():13-19. PubMed ID: 29500986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' Attitudes Towards Disclosure of Genetic Test Results to Family Members: The Impact of Patients' Sociodemographic Background and Counseling Experience.
    Gilbar R; Shalev S; Spiegel R; Pras E; Berkenstadt M; Sagi M; Ben-Yehuda A; Mor P; Perry S; Zaccai TF; Borochowitz Z; Barnoy S
    J Genet Couns; 2016 Apr; 25(2):314-24. PubMed ID: 26371363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motivation and family communication in hereditary prostate cancer genetic testing: Survey of patients from a US tertiary medical center.
    Finn CM; McCormick S; Peterson D; Niendorf KB; Rodgers LH
    J Genet Couns; 2023 Feb; 32(1):79-89. PubMed ID: 35941805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information.
    Himes DO; Clayton MF; Donaldson GW; Ellington L; Buys SS; Kinney AY
    J Genet Couns; 2016 Apr; 25(2):258-69. PubMed ID: 26245632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes.
    van den Heuvel LM; Smets EMA; van Tintelen JP; Christiaans I
    J Genet Couns; 2019 Oct; 28(5):1042-1058. PubMed ID: 31216099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.